RRD R.R. Donnelley & Sons Company

RRD Announces Vaccination Distribution Toolkit to Support Marketing and Operations for Pending COVID-19 Vaccine

R.R. Donnelley & Sons Company (RRD) (NYSE: RRD), a leading global provider of marketing and business communications, today introduces a comprehensive — for healthcare providers, government agencies, retail pharmacies, and large enterprise organizations — aimed at delivering quick-turn marketing, communication, and operational support upon the release of an FDA-authorized COVID-19 vaccine.

With several COVID-19 vaccines under review for Emergency Use Authorization by the FDA, manufacturers, care providers, and associated companies will have an immediate need for vaccine distribution, related communication, and support materials.

Immediate production of a vaccine program involves many components, e.g., regulatory compliance, multiple vendor coordination, and speed-to-market challenges. RRD’s vaccination distribution toolkit is designed to provide turnkey support in three key areas:

  1. Vaccine awareness – direct mail campaigns, digital communications, employee training materials, content and creative translations
  2. Clinician and retailer operational needs – signage and wayfinding, prep kits, temperature labels, POP displays, branded promotions and labels
  3. Post-vaccination support – care kits, proof of vaccination, second-dose reminders, tip sheets

The challenge of any large-scale, intra-pandemic vaccination effort is often compounded by the fact that many people are reluctant to get vaccinated. According to a recent survey by , more than 80% of physicians indicate that concerns regarding the safety of the COVID-19 vaccine could be the main barrier to adoption. Widespread vaccination will require extensive communications that thoughtfully incorporates messaging, imagery, reading level, and translation to resonate with a variety of populations.

“RRD’s new vaccination distribution toolkit is rooted in the company’s expertise in creating compelling communications distributed through direct mail, online channels, and physical locations,” said Ken Gammon, Vice President, RRD Healthcare Solutions.

“Once a vaccine becomes available, its distribution will require swift, efficient mobilization of awareness campaigns and associated materials. This focused coordination of proven RRD solutions will not only empower businesses with a true sense of preparedness, but provide them access to the right tools to effectively and safely seize the moment.”

About RRD

RRD is a leading global provider of multichannel business communications services and marketing solutions. With more than 35,000 employees across 29 countries, RRD offers the industry’s most comprehensive offering of solutions designed to help companies—from Main Street to Wall Street—optimize customer engagement and streamline business operations across the complete customer journey. RRD offers a comprehensive portfolio of capabilities, experience and scale that enables organizations around the world to create, manage, deliver, and optimize their marketing and business communications strategies. For more information, visit the Company's web site at .

EN
09/12/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on R.R. Donnelley & Sons Company

Moody's Ratings affirms R.R. Donnelley & Sons Company's CFR at B3

Moody's Ratings (Moody's) has affirmed R.R. Donnelley & Sons Company's (RRD) B3 corporate family rating (CFR) and the B3-PD probability of default rating. We have also affirmed the rating on the senior secured notes at B1 and the ratings on the senior unsecured notes and junior lien senior secured n...

R.R. Donnelley & Sons Company: Covenant Quality Post-Sale Snapshot: $4...

R. R. Donnelley & Sons Company's covenant package provides lower-tier moderate protection, reflecting a CQ score of 3.21

R.R. Donnelley & Sons Company: Covenant Quality Post-Sale Snapshot: $1...

R. R. Donnelley & Sons Company's covenant package provides moderate protection, reflecting a CQ score of 3.02

Moody's Ratings upgrades secured debt to B1 and assigns Caa1 rating to...

Moody's Ratings (Moody's) has upgraded R.R. Donnelley & Sons Company's (RRD) ratings for the proposed senior secured notes to B1 from B2. The upgrade reflects the changes in the proposed debt amounts and the addition of the junior lien notes in the debt structure. At the same time, we have assigned ...

R.R. Donnelley & Sons Company: Update following proposed debt raise an...

Our credit view of this issuer reflects its positive free cash flow and its good liquidity to weather ongoing pressures, offset by its demand pressures on revenue and EBITDA.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch